← Back to Search

Behavioral Intervention

Autism-adapted Group Cognitive Behavioral Therapy for Autism Spectrum Disorder

N/A
Waitlist Available
Led By Jessica M Schwartzman, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 6 months
Awards & highlights

Summary

This trial found that an autism-adapted group cognitive-behavioral treatment was feasible and acceptable for autistic adolescents, and had preliminary efficacy in treating depression.

Eligible Conditions
  • Autism Spectrum Disorder
  • Suicidal Thoughts
  • Autism
  • Depression
  • Self-Esteem

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Severity of adolescent depressive symptoms, parent-report
Severity of adolescent depressive symptoms, self-report

Trial Design

1Treatment groups
Experimental Treatment
Group I: Autism-adapted Group Cognitive Behavioral TherapyExperimental Treatment1 Intervention
Autistic adolescents (11-17 years old; middle and high school) with depression will participate in a 12-week group intervention, autism-adapted Cognitive Behavioral Therapy, to increase perception and understanding of self and to decrease the severity of depressive symptoms.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Autism-adapted Group Cognitive Behavioral Therapy
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
869 Previous Clinical Trials
678,600 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
2,486 Patients Enrolled for Autism Spectrum Disorder
Jessica M Schwartzman, PhDPrincipal InvestigatorVanderbilt University Medical Center
~6 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top